IBM
54
4
CVX
46
5
NI
75
2
PEP
41
6
BEN
45
3
PRU
57
-3
AKAM
43
3
PCG
93
2
XOM
47
5
PDCO
35
-3
SYF
85
2
EIX
77
2
CMCSA
48
2
ZTS
47
2
LLY
39
9
A
36
2
M
20
-4
MUR
43
3
ILMN
32
-3
T
50
3
IBM
54
4
CVX
46
5
NI
75
2
PEP
41
6
BEN
45
3
PRU
57
-3
AKAM
43
3
PCG
93
2
XOM
47
5
PDCO
35
-3
SYF
85
2
EIX
77
2
CMCSA
48
2
ZTS
47
2
LLY
39
9
A
36
2
M
20
-4
MUR
43
3
ILMN
32
-3
T
50
3
Financhill
Back

Inhibrx Biosciences Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54

INBX
Inhibrx Biosciences

Last Price:
13.82
Seasonality Move:
--

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Inhibrx Biosciences Price Quote

$13.82
-0.22 (-1.57%)
(Updated: November 21, 2024 at 12:45 PM ET)

Inhibrx Biosciences Key Stats

Buy
54
Inhibrx Biosciences (INBX) is a Buy
Day range:
$13.93 - $14.34
52-week range:
$10.80 - $18.95
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.1%
Volume:
89.9K
Avg. volume:
66.2K
1-year change:
0%
Market cap:
$197.2M
Revenue:
$1.6M
EPS:
$118.67

How Much Does Inhibrx Biosciences Make?

Data Unavailable

Is Inhibrx Biosciences Growing As A Company?

Data Unavailable

Inhibrx Biosciences Stock Price Performance

What Is Inhibrx Biosciences 52-Week High & Low?

Inhibrx Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Inhibrx Biosciences?

Is Inhibrx Biosciences Cash Flow Positive?

  • What Is INBX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$143.2M
  • What Is Inhibrx Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $4.2M
  • What Is Inhibrx Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$6M

Inhibrx Biosciences Return On Invested Capital

Data Unavailable

Inhibrx Biosciences Earnings Date & Stock Price

Inhibrx Biosciences Competitors

  • Who Are Inhibrx Biosciences's Competitors?
    Below is a list of companies who compete with Inhibrx Biosciences or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • CEL-SCI Corp (CVM)
    • IGC Pharma Inc (IGC)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Protalix BioTherapeutics Inc (PLX)

Inhibrx Biosciences Dividend Yield

Inhibrx Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many INBX shares are owned by institutional investors?
    12.4M INBX shares are owned by institutional investors
  • How many INBX shares are owned by insiders?
    20.4K INBX shares are owned by insiders